Schrödinger
NEWS
Computational technology company Schrödinger announced Thursday it has forged a $425 million drug design collaboration with Eli Lilly.
Pharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
The importance of artificial intelligence and machine learning is ever-increasing in the world of drug development and AstraZeneca is bolstering its participation in the tech revolution by striking a deal with New York-based Schrodinger to use that company’s advanced computing platform to help accelerate drug discovery efforts.
The financing is expected to be used to advance the company’s computational platform, as well as expand Schrödinger’s therapeutic pipeline.
Biotech and pharma companies bring on new talent to strengthen leadership teams and boards.
Companies bolstered their leadership with additions to boards of directors and c-suite offices.
JOBS
IN THE PRESS